Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. DELL
3. ROIV
4. ANET
5. NKE
6. PANW
7. CL
8. SNDK
9. TAP
10. EAT

Go back to Avere Therapeutics Announces $500 Million Private Placement to Support Development of Once-Weekly Oral IL-23 Therapy AVR-001
AVALON PHARMA (NASDAQ: AVRX) Delayed: 0.59 --0 (-0%)
Previous Close $0.59    52 Week High $1.45 
Open $0.59    52 Week Low $0.07 
Day High $0.59    P/E N/A 
Day Low $0.59    EPS $-1.24 
Volume 35,400       

(NASDAQ: NXTC) Delayed: 7.82 -0.02 (0.26%)
Previous Close $7.84    52 Week High $ 
Open $7.79    52 Week Low $ 
Day High $8.23    P/E N/A 
Day Low $7.57    EPS $ 
Volume 60,632